Matches in Nanopublications for { ?s ?p "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP375495.RAA4w-JiYrCRGD79PPiWEaD5y2Fmtkd3y6yCZhHmJkptE130_assertion description "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375495.RAA4w-JiYrCRGD79PPiWEaD5y2Fmtkd3y6yCZhHmJkptE130_provenance.
- NP375642.RA6rXY1chq0WYUGdY-TFU73jBfJCZMu0tgS8uaLTfj1Hw130_assertion description "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375642.RA6rXY1chq0WYUGdY-TFU73jBfJCZMu0tgS8uaLTfj1Hw130_provenance.
- assertion description "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP375513.RAJec400uXjKtahbiYK1NIo4Qp8Q9gXrBA9HlX3nJl2a0130_assertion description "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375513.RAJec400uXjKtahbiYK1NIo4Qp8Q9gXrBA9HlX3nJl2a0130_provenance.
- NP375504.RAnOBvporSNDSDhnbYAVGtsEu5eESLzJYdHE430xF0M_g130_assertion description "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375504.RAnOBvporSNDSDhnbYAVGtsEu5eESLzJYdHE430xF0M_g130_provenance.
- NP1053821.RAOLPTYkPqLUVsVSj5jUZeX9xSkWCHlXY91nSJYa-Rhr0130_assertion description "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053821.RAOLPTYkPqLUVsVSj5jUZeX9xSkWCHlXY91nSJYa-Rhr0130_provenance.
- NP1053822.RAkSiyRVLkKcyrD-5R2Wnl1yz2-n5Y4C0tqPpGcIm3KrQ130_assertion description "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053822.RAkSiyRVLkKcyrD-5R2Wnl1yz2-n5Y4C0tqPpGcIm3KrQ130_provenance.
- NP1053823.RAte_J8jG3N8pRF6crR09lnStScf_9XHS-VwXoBklRK-w130_assertion description "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053823.RAte_J8jG3N8pRF6crR09lnStScf_9XHS-VwXoBklRK-w130_provenance.
- NP1053824.RAtUSzy7QltcJ-Iq8zTfriJb-of7S2cKzVGTZCpjr-abU130_assertion description "[Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053824.RAtUSzy7QltcJ-Iq8zTfriJb-of7S2cKzVGTZCpjr-abU130_provenance.